about
Molecular Genetics and Biomarkers of Polyglutamine DiseasesNatural Compounds Preventing Neurodegenerative Diseases Through Autophagic Activationc-Abl inhibition delays motor neuron degeneration in the G93A mouse, an animal model of amyotrophic lateral sclerosis.Microarray analysis of gene expression by skeletal muscle of three mouse models of Kennedy disease/spinal bulbar muscular atrophyAntiandrogen flutamide protects male mice from androgen-dependent toxicity in three models of spinal bulbar muscular atrophy.Macroautophagy is regulated by the UPR-mediator CHOP and accentuates the phenotype of SBMA mice.Contractile dysfunction in muscle may underlie androgen-dependent motor dysfunction in spinal bulbar muscular atrophy.Transgenic mouse models of spinal and bulbar muscular atrophy (SBMA).Androgen-dependent loss of muscle BDNF mRNA in two mouse models of SBMA.Current status of treatment of spinal and bulbar muscular atrophy.Pathogenesis, animal models and therapeutics in spinal and bulbar muscular atrophy (SBMA).Pathogenesis and molecular targeted therapy of spinal and bulbar muscular atrophy.Defects in Neuromuscular Transmission May Underlie Motor Dysfunction in Spinal and Bulbar Muscular AtrophyTranscriptional activation of TFEB/ZKSCAN3 target genes underlies enhanced autophagy in spinobulbar muscular atrophy.Pathogenesis and therapy of spinal and bulbar muscular atrophy (SBMA).Kinase-mediated orchestration of NADPH oxidase in plant immunity.Coexisting infectious diseases on admission as a risk factor for mechanical ventilation in patients with Guillain-Barré syndrome.A case of Parkinson's disease following dystonia.Paeoniflorin eliminates a mutant AR via NF-YA-dependent proteolysis in spinal and bulbar muscular atrophy.Disrupted transforming growth factor-beta signaling in spinal and bulbar muscular atrophy.TDP-43 depletion induces neuronal cell damage through dysregulation of Rho family GTPases.Evoked potentials are useful for diagnosis of neuromyelitis optica spectrum disorder.Juxtacortical Lesions in Multiple Sclerosis: Assessment of Gray Matter Involvement Using Phase Difference-enhanced Imaging (PADRE).17-AAG, an Hsp90 inhibitor, ameliorates polyglutamine-mediated motor neuron degeneration.WRKY Transcription Factors Phosphorylated by MAPK Regulate a Plant Immune NADPH Oxidase in Nicotiana benthamiana.[Direct Gram staining of blood culture sample enabled the early diagnosis of brain abscess due to Listeria monocytogenes].Hsp105alpha suppresses the aggregation of truncated androgen receptor with expanded CAG repeats and cell toxicity.c-Jun N-terminal kinase pathway mediates Lactacystin-induced cell death in a neuronal differentiated Neuro2a cell line.Impaired muscle uptake of creatine in spinal and bulbar muscular atrophy.[Molecular-targeted therapies for spinal and bulbar muscular atrophy].Heat shock proteins in neurodegenerative diseases: pathogenic roles and therapeutic implications.[Molecular-targeted therapy for motor neuron disease].Testosterone reduction prevents phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy.Leuprorelin rescues polyglutamine-dependent phenotypes in a transgenic mouse model of spinal and bulbar muscular atrophy.Distinct acoustic features in spinal and bulbar muscular atrophy patients with laryngospasm.Sweet relief for Huntington disease.Sodium butyrate ameliorates phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy.Genistein, a natural product derived from soybeans, ameliorates polyglutamine-mediated motor neuron disease.[Treatment of spinal and bulbar muscular atrophy].Getting a handle on Huntington's disease: the case for cholesterol.
P50
Q22305784-EE225EE1-7739-46A1-8E0A-D38E734A2D75Q26746073-B3503620-7605-465E-AB14-09A4D528EDFAQ31104448-4C1E4B18-E9C5-449B-A2B9-37A582A8C0ECQ33707651-0726D77A-370B-4BA9-A371-97DB2C3D6B1FQ33707651-2E7A6510-49A8-4A4A-A209-322BD358BFDFQ33765455-E5AFE332-36F5-43DB-B049-C0C4B99FEE0CQ34055364-5E0010CA-EC69-49AD-916D-C045175A09E5Q35273916-B1544579-703C-4EA9-A795-9AD3E18709E0Q35550123-939F3CBC-3752-475D-9DE6-489DA7C21F05Q35655716-16E3D5AF-077A-4AD5-91B0-7345B97C0A5BQ36037644-AA8D9159-9DD0-47E3-BA9D-DF6BDCCB1717Q36411917-B26507B6-63D8-4603-966F-61E88BBC1F09Q36759577-7CDCB5E3-C371-4930-B56C-C120681EFA98Q36863987-AC445353-B022-4201-9FF9-AD7F98AAB71FQ37572139-3835481F-798C-4F0C-869B-4E7CFF387EDAQ38011490-1B95065C-3ADB-4754-9CBC-8A9A8F7D2D99Q38367703-22392E01-9C22-4164-A7A8-1285EEED9E88Q38914130-6904D825-4754-4612-BE11-7B68D1796998Q38921042-776310B3-6BDB-4B7C-9656-2EBE6DB1A557Q39022920-626980C2-BA97-4779-B7A5-19759CD2E1C4Q39712232-66FB8A05-C8D0-4D80-96C6-F012572556A0Q39836728-91CA27C5-8986-481D-B9CF-AA4C3DD4E1ABQ39846961-E95E8BE3-C0CA-48A0-8592-9AE8DD465038Q40027340-C2EF8B61-DAA0-4D0F-BBD6-C89DE919E53AQ40374915-FFB764DC-2D73-484C-92A6-98CDFFB09457Q40536540-FAECFCE3-33F9-468B-8D62-E1CA8AABD27EQ40625843-42CDF14B-97EE-42AA-BBA1-E23A21D0D386Q40652242-E274CB3F-BAC6-4B81-B0D8-5D51C3CF1346Q40683757-C7A135AA-B6EC-46E2-A76E-0A571F76C30DQ42063287-CD0F2DA3-5959-4E26-828E-0735D2DB35C8Q43210683-DC244622-E5FB-4412-A07A-A4294F81BC25Q43215480-51CAE7A9-ECC5-46C5-B71E-2D8B8A0E27C2Q43288183-590BC87B-D93A-449A-B52A-8F50228812A0Q44173664-9DF4F092-D13C-41AB-9ACA-834F57289C23Q44446014-6A4EB854-2A67-4FDB-80E5-B65741300C27Q44588681-375526F5-8E44-4871-9701-67BDDEF59702Q44754231-6AFCDD15-9459-485A-9EB1-7ADCA1C83D65Q44854729-6AF709A1-D8FE-410B-9E10-C9CC13F5A703Q45146825-153A39D2-5F48-445A-AE01-49E762432A97Q45155608-4BC90C6F-7FF3-4BDF-BE45-79468DB46802
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Hiroaki Adachi
@ast
Hiroaki Adachi
@en
Hiroaki Adachi
@es
Hiroaki Adachi
@nl
Hiroaki Adachi
@sl
type
label
Hiroaki Adachi
@ast
Hiroaki Adachi
@en
Hiroaki Adachi
@es
Hiroaki Adachi
@nl
Hiroaki Adachi
@sl
prefLabel
Hiroaki Adachi
@ast
Hiroaki Adachi
@en
Hiroaki Adachi
@es
Hiroaki Adachi
@nl
Hiroaki Adachi
@sl
P1053
I-2669-2012
P106
P1153
35486813000
P21
P31
P3829
P496
0000-0002-9302-4663